Inventor

CHENG SENG H

US60 patents

⚠️ This page may combine multiple inventors who share the name “CHENG SENG H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHENG SENG H

GENZYME CORP

Cationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic molecules

Cationic amphiphile/DNA complexes

Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules

Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy

Cationic amphiphiles for intracellular delivery of therapeutic molecules

Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases

Compositions and method for treating lysosomal storage disease

Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules

Gene therapy for neurodegenerative disorders

Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor

Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules

Gene therapy for neurodegenerative disorders

Methods of treating diabetes mellitus

Methods of enhancing lysosomal storage disease therapy by modulation of cell surface receptor density

Cationic amphiphiles for intracellular delivery of therapeutic molecules

Transgene expression system for increased persistence

Cationic amphiphile compositions for intracellular delivery of therapeutic molecules

Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules

Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules

Gene therapy for neurodegenerative disorders

Oligosaccharides comprising an aminooxy group and conjugates thereof

Intraventricular enzyme delivery for lysosomal storage diseases

Oligosaccharides comprising an aminooxy group and conjugates thereof

Method of lowering blood glucose

Compositions and methods for treating spinal muscular atrophy

Glucosylceramide synthase inhibitors

Gene therapy for neurodegenerative disorders

Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy

Methods of treating fatty liver disease

Small molecule chloride transport

Slow intraventricular delivery

IONIS PHARMACEUTICALS INC

Modulation of huntingtin expression

Modulation of Huntington expression

Modulation of huntingtin expression

Modulation of huntingtin expression

Modulation of huntingtin expression

ISIS PHARMACEUTICALS INC

Modulation of dystrophia myotonica-protein kinase (DMPK) expression

Modulation of huntingtin expression

DODGE JAMES

Intraventricular enzyme delivery for lysosomal storage diseases

Gene therapy for spinal cord disorders

BENNETT C FRANK

Compositions and methods for modulation of SMN2 splicing in a subject

BIOGEN MA INC

Compositions and methods for modulation of SMN2 splicing in a subject

ZHAO HONGMEI

Methods of treating fatty liver disease

HUNG GENE

Modulation of huntingtin expression

SCHLOSSMACHER MICHAEL

Treatment of synucleinopathies

ZHU YUNXIANG

Oligosaccharides comprising an aminooxy group and conjugates thereof

BRIGHAM & WOMENS HOSPITAL INC

Treatment of synucleinopathies

MEEKER DAVID

Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases

SANOFI SA

Multispecific binding molecules having specificity to dystroglycan and laminin-2

NATOLI THOMAS A

Method of treating polycystic kidney diseases with ceramide derivatives